Clinical features and accompanying findings of Pseudo‐Bartter Syndrome in cystic fibrosis
暂无分享,去创建一个
U. Ozcelik | N. Kiper | E. Çakır | V. Şen | D. Can | F. Orhan | O. Yılmaz | N. Sapan | D. Altintas | E. Topal | O. Keskin | D. Doğru | H. Yuksel | G. Cinel | G. Çaltepe | Z. Tamay | S. Pekcan | M. Kose | N. Emiralioğlu | E. Yalcin | G. Tuğcu | A. Ozdemir | Z. G. Gayretli Aydın | N. Çobanoğlu | A. Kılınç | Ş. Çekiç | A. Sasihuseyinoglu | T. Ramasli Gursoy | A. Aslan | A. Bingol | A. Suleyman | H. SelİmoĞlu Şen | A. E. Başaran | T. Sismanlar Eyuboglu | H. Çokuğraş | M. Hangul | S. Bilgic Eltan | C. Bal | H. Yazan | O. Ercan | Lina Alshadfan | Sevgi Bilgic Eltan | E. Yalçın | T. Şişmanlar Eyuboglu | H. Selimoğlu Şen
[1] G. Savoldi,et al. Should isolated Pseudo‐Bartter syndrome be considered a CFTR‐related disorder of infancy? , 2019, Pediatric pulmonology.
[2] H. W. Dilanthi,et al. Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka , 2019, BMC Medical Genetics.
[3] S. Stanojevic,et al. Incidence and risk factors of paediatric cystic fibrosis-related diabetes. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[4] J. Carr,et al. Registry , 2019, Definitions.
[5] Vikesh K. Singh,et al. Pancreatic insufficiency in Cystic Fibrosis. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[6] F. Accurso,et al. Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[7] A. Zolin,et al. ECFS Patient Registry : annual data Report : 2013 data , 2016 .
[8] A. Brightwell,et al. Episodic seasonal Pseudo-Bartter syndrome in cystic fibrosis. , 2014, Paediatric respiratory reviews.
[9] A. Najada,et al. Pseudo-bartter syndrome, pattern and correlation with other cystic fibrosis features. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[10] G. Cutting,et al. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients , 2010, Respiratory research.
[11] M. Ma. Pseudo-Bartter as an initial presentation of cystic fibrosis. A case report and review of the literature. , 2010 .
[12] U. Ozcelik,et al. An epidemic of pseudo-Bartter syndrome in cystic fibrosis patients , 2007, European Journal of Pediatrics.
[13] Elena Infante,et al. Hyponatremic Dehydration as a Presentation of Cystic Fibrosis , 2006, Pediatric emergency care.
[14] N. Kiper,et al. Clinical features and treatment approaches in cystic fibrosis with pseudo-Bartter syndrome , 2005, Annals of tropical paediatrics.
[15] S. Emerson,et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study , 2003, The Lancet.
[16] A. Morabito,et al. Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome , 2002, Hepatology.
[17] K. Al-mobaireek,et al. Cystic fibrosis in Saudi Arabia: common and rare presentations. , 1995, Annals of tropical paediatrics.